Sampre Nutritions Complete Financial Statements
In FY2026, Sampre Nutritions (SAMPRE) reported revenue ₹16 Cr, net profit ₹1 Cr and EPS ₹0.64, with a net profit margin of 6.3% and ROE of 0.9%. Full financial statements from FY2023 to FY2026 (4 years) — income statement, balance sheet and cash flow in ₹ Crores. Download as Excel or CSV.
Complete Financial Data Export
Profitability Ratios
Balance Sheet Ratios
SAMPRE Revenue, Net Profit & EBITDA — Year-on-Year Growth
SAMPRE YoY (Mar 2025 vs Mar 2026) — revenue +100.0%, net profit +114.3%, EBITDA +116.7%, expenses +7.1%. Compare with SAMPRE fair value estimate to assess whether the stock is under or overvalued.
SAMPRE Income Statement — Revenue, EBITDA & Net Profit
Sampre Nutritions revenue ₹16 Cr, EBITDA ₹1 Cr, net profit ₹1 Cr, EPS ₹0.64 (2026) — net profit margin 6.3%. For live price, earnings ratios and company overview, see Sampre Nutritions stock price NSE.
| Particulars | Mar 2026 | Jun 2026 | Sept 2025 | Mar 2025 | Jun 2025 | Dec 2025 | Sept 2024 | Mar 2024 | Jun 2024 | Dec 2024 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 16 | 15 | 10 | 8 | 11 | 7 | 7 | 5 | 5 | 6 |
| Expenses | 15 | 13 | 8 | 14 | 10 | 6 | 6 | 3 | 4 | 5 |
| EBITDA | 1 | 2 | 2 | -6 | 1 | 2 | 1 | 2 | 1 | 1 |
| Operating Profit Margin % | 3.00% | 10.00% | 20.00% | -81.00% | 13.00% | 20.00% | 14.00% | 43.00% | 21.00% | 8.00% |
| Depreciation | 1 | 1 | 1 | 1 | 0 | 1 | 0 | 1 | 0 | 0 |
| Interest | 1 | 0 | 0 | 1 | 0 | 0 | 0 | 1 | 0 | 1 |
| Profit Before Tax | 0 | 1 | 1 | -7 | 1 | 1 | 0 | 1 | 0 | -1 |
| Tax | -1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net Profit | 1 | 1 | 1 | -7 | 1 | 1 | 0 | 1 | 0 | -1 |
| Earnings Per Share (₹) | 0.64 | 0.33 | 0.41 | -3.50 | 0.34 | 0.06 | 0.18 | 0.65 | 0.11 | -0.30 |
SAMPRE Balance Sheet — Assets, Liabilities & Shareholders' Equity
SAMPRE total assets ₹134 Cr, total equity ₹107 Cr, total liabilities ₹ Cr (2026) — ROE 0.9%.
| Particulars | 2026 | 2025 | 2024 | 2023 |
|---|---|---|---|---|
| ASSETS | ||||
| Total Assets | 134 | 115 | 45 | 44 |
| Current Assets | 23 | 16 | 16 | 16 |
| Fixed Assets | 20 | 20 | 21 | 21 |
| Capital Work in Progress | 5 | 5 | 6 | 4 |
| Investments | 84 | 74 | 0 | 0 |
| Other Assets | 26 | 17 | 18 | 19 |
| LIABILITIES | ||||
| Total Liabilities | ||||
| Current Liabilities | 13 | 11 | 10 | 11 |
| Non-Current Liabilities | ||||
| SHAREHOLDERS' EQUITY | ||||
| Total Equity | 107 | 91 | 23 | 21 |
| Share Capital | 48 | 21 | 7 | 7 |
| Reserves & Surplus | 60 | 68 | 12 | 12 |
SAMPRE Cash Flow Statement — Operating, Investing & Financing
Sampre Nutritions operating cash flow ₹-1 Cr, investing ₹-3 Cr, financing ₹4 Cr, net cash flow ₹0 Cr (2026).
| Particulars | March 2026 | March 2025 | March 2024 | March 2023 |
|---|---|---|---|---|
| Operating Activities | -1 | 0 | 4 | 1 |
| Investing Activities | -3 | -75 | -4 | -4 |
| Financing Activities | 4 | 75 | 0 | 4 |
| Net Cash Flow | 0 | 0 | 0 | 0 |